Table 2.
Summary of results obtained in studies that evaluated the long-term response of left ventricular mass to either medical treatment or surgical treatment in primary aldosteronism.
| Study | Follow-up years | Medical treatment | Surgical treatment | ||
|---|---|---|---|---|---|
| Baseline | End of study | Baseline | End of study | ||
| Catena et al., 2007 [28] |
6.4 | 52 ± 2 | 44 ± 2† | 53 ± 2 | 43 ± 2∗ |
| Giacchetti et al.∗
2007 [49] |
3.7 | 135 ± 4 | 125 ± 7 | 126 ± 5 | 116 ± 5∗ |
| Bernini et al., 2012 [50] |
2.7 | 65 ± 2 | 65 ± 3 | 58 ± 2 | 49 ± 3∗ |
| Rossi et al., 2013 [48] |
3.0 | 50 ± 1 | 47 ± 1 | 53 ± 1 | 49 ± 1∗ |
Values of left ventricular mass index are expressed as g/m2.7 except for the study of Giacchetti et al. (∗) that expressed as left ventricular mass (g). † P < 0.05 versus baseline.
Data in the table have been included in a meta-analysis [51] showing that effects of medical and surgical treatment of primary aldosteronism on left ventricular mass are not significantly different.